Skip to content

Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss

The Effects of a Weight Loss Diet Containing Medium Chain Triglyceride Oil, Versus Olive Oil, on Body Composition in Free-Living Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00529919
Acronym
Muffin
Enrollment
53
Registered
2007-09-14
Start date
2005-03-31
Completion date
2007-06-30
Last updated
2007-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Keywords

Overweight, Obesity, Weight loss, Medium chain triglycerides, Cardiovascular disease risk

Brief summary

The primary aim of this research project is to determine whether the incorporation of food products containing medium chain triglyceride (MCT) oil in a weight-loss program results in a different degree of weight-loss and total and regional fat mass loss than the incorporation of extra light olive oil. The secondary goals are to test whether there are differences in in metabolic risk profile changes between the 2 diets. We hypothesize that men and women who consumed MCT oil as part of their weight loss program will lose more weight and body fat than those who consume olive oil in their weight loss diet.

Interventions

DIETARY_SUPPLEMENTWeight loss

Weight loss study including consumption of either 22-25 g of medium chain triglyceride oil or olive oil

Sponsors

International Life Sciences Institute
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
19 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* body mass index 27-33 kg/m2 * pre-menopausal women * weight stable for at least 6 months * normal score on Brief Symptoms Inventory questionnaire

Exclusion criteria

* chronic disease * weight loss treatment * medication known to affect body weight * unstable blood pressure, glucose, lipid levels

Design outcomes

Primary

MeasureTime frame
Change in body weight and fat mass, change in plasma lipid concentrations, fasting glucose and fasting insulin16 weeks

Secondary

MeasureTime frame
Change in blood pressure, change in fat-free mass16 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026